5 warning signs health care fraud could be driving up your insurance costs
Health insurance premiums continue to rise, and most people assume the reason is simple: health care is expensive.
While the cost of care is a major driver, other factors often operate in the background, affecting businesses, employees, and families: fraud, waste, and abuse within parts of the health care system.
These schemes rarely look like obvious scams. Instead, they’re often embedded within otherwise legitimate medical claims, making them difficult to detect. Over time, however, improper billing practices, unnecessary procedures, or referral-driven treatment patterns can add millions of dollars in expenses to employer health plans and insurance systems.
Because those costs are ultimately borne by employers, insurers, and patients, even people who never engage in questionable medical activity may still feel the financial effects.
Understanding how these schemes work and the warning signs they create can help organizations and individuals recognize potential problems earlier.
Warning Sign #1: A sudden surge in identical procedures
A common early signal shows up in the data, like a sharp increase in the same type of procedure among a specific group of patients.
For example, multiple employees at the same company, or members of the same family, may undergo identical surgeries within a short period of time.
On paper, each treatment may appear justified. But when patterns emerge across dozens of claims, it can sometimes suggest a referral pipeline designed to generate higher volumes of reimbursable procedures.
These patterns aren’t proof of fraud, but they’re rarely random.
Warning Sign #2: Patients traveling long distances for routine care
Travel is expected for highly specialized treatment, but is less typical for routine care. When patients regularly travel hundreds of miles for procedures that are widely available closer to home, it may be a red flag.
In certain schemes, patients may be encouraged to visit specific clinics or surgery centers because those facilities are connected to referral arrangements or marketing networks designed to generate patient volume. Long-distance travel for common interventions can sometimes signal financial incentives operating behind the scenes.
Warning Sign #3: Medical costs that rise faster than expected
Employer health plans typically experience gradual cost changes over time. When plan spending suddenly spikes, especially for a narrow set of procedures or providers, it deserves a closer look.
Organizations might notice:
- Unexpected increases in claims tied to a particular surgery or treatment
- A sudden rise in medical leave among employees
- Significant and unexpected jumps in annual health plan expenses
For companies that operate self-funded health coverage, these increases can have immediate financial consequences because the employer pays the claims directly.
Over time, those higher prices can translate into increased premiums, higher deductibles, or reduced benefits for employees.
Warning Sign #4: Financial incentives that influence referrals
Some health care fraud schemes involve financial relationships that improperly influence where patients receive care.
Certain arrangements may involve payments labeled as consulting or “medical director” roles that are tied, directly or indirectly, to patient volume. Others may rely on third-party marketing firms to recruit patients for specific treatments. In some cases, individuals are incentivized to steer coworkers, friends, or family members toward particular providers.
While many business relationships in health care are legitimate and regulated, referral arrangements driven primarily by financial incentives can create risks for health benefits and patients.
Warning Sign #5: Waived co-pays or other unusual payment arrangements
Health insurance plans are designed to include some level of cost-sharing, such as co-pays or co-insurance. These payments are intended to help patients make informed decisions about care.
In some questionable arrangements, however, providers may offer to waive those expenses entirely in order to encourage patients to undergo procedures.
While this can appear attractive to patients, it may remove an important safeguard from the health plan design and lead to unnecessary services being performed.
Because of this, waived cost-sharing requirements can sometimes signal a need for further review.
Why health care fraud can be hard to detect
One of the biggest challenges with health care fraud is that it often hides inside otherwise legitimate claims.
Health plans typically review claims individually to confirm that services were billed correctly. Fraud schemes, however, often become visible only when patterns across dozens, or even hundreds, of claims are analyzed together.
In many cases, the first warning signs do not come from data alone. They come from people noticing that something seems unusual.
An HR manager might observe that an unusually high number of employees are taking medical leave. Workers might notice that several colleagues are traveling to the same facility for similar procedures.
These early observations can sometimes become the starting point for deeper investigations.
Why awareness matters
Health care fraud does not just affect insurers or large corporations. It affects anyone who participates in the health care system.
Every unnecessary procedure, inflated bill, or improper referral can contribute to rising health care costs nationwide.
Greater awareness—from employers, patients, and providers alike—can help identify problems earlier and protect the resources that health plans are meant to provide.
Health care may remain expensive, but unchecked fraud ensures it becomes unsustainable.
Katherine “Kate” Bowles is a Health Care Business Lawyer at Fennemore and a Registered Nurse who draws upon her in-depth industry experience to provide insightful guidance and strategic advice on health care disputes and compliance issues. For more than 12 years, she has worked with health care businesses and health plans throughout the Western United States and currently advises several state-level trade groups on regulatory and legislative matters. She can be reached at kbowles@fennemorelaw.com.